• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Higher levels of screen use associated with poorer mental health in Canadian children and youth during the COVID-19 pandemic

byYuchen DaiandMichael Pratte
December 28, 2021
in Pediatrics, Psychiatry, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Children with higher levels of screen time had significantly higher levels of mental health symptoms, with different forms of screen use associated with distinct psychological symptoms, suggesting that not all screen use is equal.

2. These findings may help inform public health guidelines and policies that consider different forms of screen use in the prevention of mental health disorders in children during the pandemic and beyond.

Evidence Rating Level: 2 (Good)

Study Rundown: The restrictions brought on by the COVID-19 pandemic has undoubtedly increased screen use in children and youth, serving as an essential platform for their learning, entertainment, social interactions, and leisure. However, longitudinal data on the mental health effects of increased screen time through its various forms is lacking. This cohort study assessed whether specific forms of screen use (television [TV] or digital media, video games, electronic learning, and video-chatting time) were associated with symptoms of depression, anxiety, conduct problems, irritability, hyperactivity, and inattention in children and youth during COVID-19. The main outcomes were parent-reported symptoms of child depression, anxiety, conduct problems and irritability, and hyperactivity/inattention assessed using validated standardized tools. Among 2026 children with 6648 total observations, children with higher levels of screen time had significantly higher levels of mental health symptoms, with various forms of screen use associated with distinct psychological symptoms, suggesting that not all screen use is equal. A limitation of this study was the predominance of children of European ancestry included in the study cohort, owing to different socioeconomic and cultural demographics and thus, limiting the generalizability of the findings to the general population.

Click to read the study in JAMA Network Open

Relevant Reading: Effects of screentime on the health and well-being of children and adolescents: a systematic review of reviews

RELATED REPORTS

One in Six Medicare Beneficiaries Use Telehealth for Essential Care

Middle-aged and older Canadians at high risk of obstructive sleep apnea may have worse mental health outcomes

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

In-Depth [prospective cohort]: This longitudinal cohort study included 2026 children from the province of Ontario, Canada with 6648 total observations between May 2020 and April 2021. Children were 2 to 18 years old divided across 4 cohorts: 2 community cohorts and 2 clinically referred cohorts, where parents completed questionnaires about their children’s health behaviors and mental health symptoms during COVID-19. In younger children (mean [SD] age, 5.9 [2.5] years; 275 [51.7%] male), higher TV or digital media time was associated with higher levels of conduct problems (age 2-4 years: β, 0.22 [95%CI, 0.10-0.35]; P < .001; age ≥4 years: β, 0.07 [95%CI, 0.02-0.11]; P = .007) and hyperactivity/inattention (β, 0.07 [95%CI, 0.006-0.14]; P = .04). In older children and youth (mean [SD] age, 11.3 [3.3] years; 844 [56.5%] male), higher TV or digital media consumption was associated with higher levels of depression, anxiety, and inattention. In particular, increased video game time was associated with higher levels of depression, irritability, inattention, and hyperactivity and increased electronic learning time was associated with higher levels of depression and anxiety.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: electronicsmental healthscreen time
Previous Post

Adjuvant chemotherapy may potentially be avoided in breast cancer patients with lymph node-positive disease

Next Post

Prevalence of major depressive and anxiety disorders has increased during the COVID-19 pandemic

RelatedReports

2 Minute Medicine Rewind October 21, 2019
Public Health

One in Six Medicare Beneficiaries Use Telehealth for Essential Care

February 16, 2026
Admission may not be needed following sleep apnea surgery
Chronic Disease

Middle-aged and older Canadians at high risk of obstructive sleep apnea may have worse mental health outcomes

January 12, 2026
FDA-regulated clinical trials rarely report violations
The Scan by 2 Minute Medicine®

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

October 22, 2025
Lower vulvar cancer-related mortality in African Americans
Pharma

Wegovy survey finds decline in constant food thoughts and improved well being

September 24, 2025
Next Post
Parents often unaware of adolescents’ suicidal thoughts

Prevalence of major depressive and anxiety disorders has increased during the COVID-19 pandemic

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Vitamin D supplementation not supported to treat first-episode psychosis

Food environment associated with gestational diabetes

Prevalence of diabetes mellitus in China, 2013-2018

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Adults with attention-deficit/hyperactivity disorder are at higher risk of poor long-term adherence to antihypertensive therapy
  • 150 minutes of moderate-to-vigorous physical activity per week may reduce cardiovascular risk in overweight or obese adults
  • 2 Minute Medicine: Pharma Roundup – Merck and Mayo Clinic’s AI precision medicine lab, Novartis’ remibrutinib hits Phase III hive endpoint, FDA grants priority review for iberdomide in myeloma, oral infigratinib boosts growth velocity in achondroplasia, and shingles vaccine/sildenafil linked to lower Alzheimer’s risk [February 2026]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.